Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Current Pharmaceutical Design|September 15, 2012
Inhibition of RET activated pathways: novel strategies for therapeutic intervention in human cancersLibero Santarpia, Giulia BottaiInternational Journal of Molecular Sciences|April 28, 2023
Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast CancerGyöngyi Munkácsy, Libero Santarpia, Balázs GyőrffyCurrent Opinion in Pharmacology|November 28, 2016
Role of inflammation in obesity-related breast cancerElisa Crespi, Giulia Bottai, Libero SantarpiaThe Oncologist|June 23, 2025
Exploring immune activation patterns in HER2-low and HER2-ultralow breast cancer subtypesGyöngyi Munkácsy, Libero Santarpia, Balázs GyőrffyCurrent Cancer Drug Targets|October 11, 2015
A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast CancerOtília Menyhárt, Libero Santarpia, Balázs GyőrffyBiomedicines|February 25, 2022
Gene Expression Profiling in Early Breast Cancer-Patient Stratification Based on Molecular and Tumor Microenvironment FeaturesGyöngyi Munkácsy, Libero Santarpia, Balázs GyőrffyAnnals of the New York Academy of Sciences|November 15, 2006
Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndromeLibero Santarpia, Daniela Lapa, Salvatore BenvengaNature Reviews. Clinical Oncology|October 27, 2010
Breast cancer assessment tools and optimizing adjuvant therapyCatherine Oakman, Libero Santarpia, Angelo Di LeoEndocrine-Related Cancer|October 22, 2009
MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotypeLibero Santarpia, Milena Nicoloso, George A CalinEndocrine Reviews|July 8, 2010
The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumorsLei Ye, Libero Santarpia, Robert F GagelPageof 7